Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer
Hill, Andrew G, Findlay, Michael P, Burge, Matthew E, Jackson, Christopher, Alfonso, Pilar Garcia, Samuel, Leslie, Ganju, Vinod, Karthaus, Meinolf, Amatu, Alessio, Jeffery, Mark, Bartolomeo, Maria Di, Bridgewater, John, Coveler, Andrew L, Hidalgo, Manuel, Kapp, Amy V, Sufan, Roxana I, McCall, Bruce B, Hanley, William D, Penuel, Elicia M, Pirzkall, Andrea, Tabernero, Josep
Published in Clinical cancer research (15.05.2018)
Published in Clinical cancer research (15.05.2018)
Get full text
Journal Article
Characterization of CD20 expression loss as a mechanism of resistance to mosunetuzumab in patients with relapsed/refractory B-cell non-Hodgkin lymphomas
Schuster, Stephen J., Huw, Ling-Yuh, Bolen, Christopher R., Assouline, Sarit E., Bartlett, Nancy L., Budde, L Elizabeth, Matasar, Matthew J., Koeppen, Hartmut, Piccione, Emily C., Wilson, Deanna, Wei, Michael C., Yin, Shen, Penuel, Elicia M.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Neoantigens in Patients with De Novo Follicular Lymphoma: Results from the PRIMA Study
Henneges, Carsten, Jin, Dexter X, Venstrom, Jeffrey M, Trabucco, Sally E, Nielsen, Tina G, Penuel, Elicia M., Huet, Sarah, Salles, Gilles, Paulson, Joseph N
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
SUNMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab in combination with polatuzumab vedotin vs rituximab plus gemcitabine and oxaliplatin in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
Westin, Jason, Olszewski, Adam J, Fogliatto, Laura, Kim, Won Seog, Shin, Ho-Jin, Jeon, Young-Woo, Norasetthada, Lalita, Pavlovsky, Astrid, Rego, Eduardo, Wu, Hao, Yin, Shen, Batlevi, Connie Lee, Pham, Song, Penuel, Elicia M., Jing, Jing, Wei, Michael C., Budde, Lihua Elizabeth
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Subcutaneous Mosunetuzumab in Relapsed or Refractory B-Cell Lymphoma: Promising Safety and Encouraging Efficacy in Dose Escalation Cohorts
Matasar, Matthew J, Cheah, Chan Yoon, Yoon, Dok Hyun, Assouline, Sarit E, Bartlett, Nancy L., Ku, Matthew, Giri, Pratyush, Johnston, Anna, Flinn, Ian W., Goy, Andre H., Tzachanis, Dimitrios, O'Hear, Carol, Yin, Shen, To, Iris, Sarouei, Kati, Li, Chi-Chung, Bender, Brendan C., Penuel, Elicia M., Huang, Huang, Budde, L. Elizabeth
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Mosunetuzumab Shows Promising Efficacy in Patients with Multiply Relapsed Follicular Lymphoma: Updated Clinical Experience from a Phase I Dose-Escalation Trial
Assouline, Sarit E, Kim, Won Seog, Sehn, Laurie H., Schuster, Stephen J., Cheah, Chan Yoon, Nastoupil, Loretta J., Shadman, Mazyar, Yoon, Sung-Soo, Matasar, Matthew J, Diefenbach, Catherine, Gregory, Gareth P., Bartlett, Nancy L., Wei, Michael C., Doral, Michelle Y., Yin, Shen, Negricea, Raluca, Li, Chi-Chung, Penuel, Elicia M., Huang, Huang, Budde, L. Elizabeth
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Abstract 3527: Assessing signal modulation in preclinical models and tumor tissue from patients enrolled in a Phase 1 study of the HER3/EGFR dual action antibody, MEHD7945A (MEHD), as an exploratory pharmacodynamic (PD) analysis
Penuel, Elicia M., Burton, Luciana, Stern, Howard, Mark, Lackner, Pirzkall, Andrea, Amler, Lukas, Schaefer, Gabriele
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Chinese hamster ovary cells contain transcriptionally active full-length type C proviruses
Lie, Y S, Penuel, E M, Low, M A, Nguyen, T P, Mangahas, J O, Anderson, K P, Petropoulos, C J
Published in Journal of Virology (01.12.1994)
Published in Journal of Virology (01.12.1994)
Get full text
Journal Article